Moreover, multivariate analyses showed that the expression of FEZF1‐AS1 (P = .014), depth of invasion (P = .003), TNM stage (P < .001), and lymph node metastasis (P = .022) were independent indicators for OS prognosis in EOC patients (Figure 1F). The gene discussed is FEZF1; the disease is metastatic malignant neoplasm in the lymph nodes.